Skip to content
10-Q/A

Quarterly Report

IMMIX BIOPHARMA, INC. IMMX

0001641172-25-011519

← back to feed
Filed
May 19, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 6, 2025 27.88M sh